Page last updated: 2024-08-24

prostratin and 12-deoxyphorbolphenylacetate

prostratin has been researched along with 12-deoxyphorbolphenylacetate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blumberg, PM; Krsmanovic, L; Szallasi, Z1
Acs, P; Blumberg, PM; Bögi, K; Lorenzo, PS; Szállási, Z; Wagner, GS1
Blumberg, PM; Bocklandt, S; Hamer, DH1
Kee, JM; Warrington, JM; Wender, PA1

Other Studies

4 other study(ies) available for prostratin and 12-deoxyphorbolphenylacetate

ArticleYear
Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumor promotion in CD-1 mouse skin.
    Cancer research, 1993, Jun-01, Volume: 53, Issue:11

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Mice; Papilloma; Phorbol Esters; Skin Neoplasms; Tetradecanoylphorbol Acetate

1993
Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity.
    Cancer research, 1998, Apr-01, Volume: 58, Issue:7

    Topics: 3T3 Cells; Animals; Binding Sites; Blotting, Western; Carcinogens; Diterpenes; Indoles; Isoenzymes; Lactams; Ligands; Mice; Mutagenesis, Site-Directed; Phorbol Esters; Protein Kinase C; Protein Kinase C-delta; Protein Structure, Tertiary; Terpenes

1998
Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate.
    Antiviral research, 2003, Volume: 59, Issue:2

    Topics: Anti-HIV Agents; Carcinogens; CD4 Antigens; Cell Line; Down-Regulation; Gene Expression Profiling; HIV Infections; HIV-1; Humans; Macromolecular Substances; Models, Molecular; Oligonucleotide Array Sequence Analysis; Phorbol Esters; Protein Kinase C; Receptors, CXCR4; Virus Activation; Virus Replication

2003
Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV.
    Science (New York, N.Y.), 2008, May-02, Volume: 320, Issue:5876

    Topics: Anti-HIV Agents; Chemotherapy, Adjuvant; HIV-1; Humans; Models, Molecular; Phorbol Esters; Phorbols; Viral Load; Virus Latency

2008